GE Healthcare CEO on Q3 beat and AI's impact

GE Healthcare CEO Peter Arduini called radiopharmaceuticals a fast-growing field advancing care in cancer, cardiac imaging and neurology, including Alzheimer's-related approaches. Because these products have short half-lives and can dissipate by day's end, control of manufacturing and supply chains is especially important. He also discussed the company's third-quarter earnings beat and AI's impact.

• GE HealthCare hires chief artificial intelligence officer2026-09-30